Jump to content
Main menu
Navigation
●Main page
●Contents
●Current events
●Random article
●About Wikipedia
●Contact us
●Donate
Contribute
●Help
●Learn to edit
●Community portal
●Recent changes
●Upload file
Search
●Create account
●Log in
●Create account
● Log in
Pages for logged out editors learn more
●Contributions
●Talk
(Top)
1
References
Drozitumab
●العربية
●中文
Edit links
●Article
●Talk
●Read
●Edit
●View history
Tools
Actions
●Read
●Edit
●View history
General
●What links here
●Related changes
●Upload file
●Special pages
●Permanent link
●Page information
●Cite this page
●Get shortened URL
●Download QR code
●Wikidata item
Print/export
●Download as PDF
●Printable version
Appearance
From Wikipedia, the free encyclopedia
Drozitumab is a human monoclonal antibody in development for the treatment of cancers.[1] It targets Tumour Necrosis Factor Related Apoptosis-inducing Ligand (TRAIL), whose receptors are found on the surface of many types of malignant cells.[2] Drozitumab was developed by Genentech.
Although drozitumab was studied in phase II trials for treating chondrosarcoma, colorectal cancer, non-Hodgkin lymphoma, and non-small cell lung cancer, development has been halted due to lack of clinical response.[2]
References[edit]
^ a b "Drozitumab". AdisInsight. Retrieved 31 January 2017.
t
e
t
e
Retrieved from "https://en.wikipedia.org/w/index.php?title=Drozitumab&oldid=1160193376"
Categories:
●Drugs not assigned an ATC code
●Monoclonal antibodies
●Abandoned drugs
●Monoclonal antibody stubs
●Antineoplastic and immunomodulating drug stubs
Hidden categories:
●Articles with short description
●Short description matches Wikidata
●Articles with changed CASNo identifier
●Chemicals that do not have a ChemSpider ID assigned
●Articles with changed KEGG identifier
●Articles without EBI source
●Chemical pages without DrugBank identifier
●Articles without InChI source
●Drugs with no legal status
●Drugboxes which contain changes to verified fields
●Drugboxes which contain changes to watched fields
●Drugs that are a monoclonal antibody
●All stub articles
●This page was last edited on 14 June 2023, at 23:51 (UTC).
●Text is available under the Creative Commons Attribution-ShareAlike License 4.0;
additional terms may apply. By using this site, you agree to the Terms of Use and Privacy Policy. Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc., a non-profit organization.
●Privacy policy
●About Wikipedia
●Disclaimers
●Contact Wikipedia
●Code of Conduct
●Developers
●Statistics
●Cookie statement
●Mobile view